Vivek Thanki
Lawyers
Associate in our Corporate practice, based in London. Previously completed a rotation in Capital Markets in our New York office.
Vivek advises on a range of private and public mergers and acquisitions, takeovers and securities offerings and listings.
Experience highlights
- Gilead Sciences $405 million acquisition of MiroBio
- NewMed Energy proposed combination with Capricorn Energy
- Made.com £775.3 million IPO and London listing
- Lightyear Capital acquisition of Wren Sterling
- Boots establishment of €1 billion commercial paper programme and application to the Bank of England’s Covid Corporate Financing Facility
- Mereo BioPharma combination with OncoMed Pharmaceuticals
- MSCI notes offerings worth $1.8 billion
- Nuvei financing $889 million takeover of SafeCharge
- Verisk Analytics $200 million SEC-registered senior notes reopening
- Advising investment banks as financial advisers, sponsors and/or underwriters in connection with:
- Alphawave IP Group’s £856 million IPO
- Unilever’s simplification of its dual listed company structure
- Hammerson’s £552 million rights issue on the London Stock Exchange
- Datadog’s $648 million Nasdaq IPO and subsequent $747.5 million convertible notes offering
- Electrocomponents’ £180 million placing and retail offer of new shares
- Anglo Pacific’s £46 million placing and retail offer of new shares
- The Emirate of Abu Dhabi’s series of investment grade bond offerings totaling $15 billion
- The Rank Group’s £115.3 million takeover of Stride Gaming
Insights
Education
LL.B., Law, King's College London, Dickson Poon School of Law
- with honours
Professional history
- Davis Polk since 2018
Qualifications and admissions
- England and Wales